Advertisement
Advertisement

ONC

ONC logo

BeOne Medicines Ltd. - ADR

268.20
USD
Sponsored
+3.72
+1.41%
Jun 15, 16:00 UTC -4
Closed
exchange

After-Market

266.07

-2.13
-0.79%

ONC Earnings Reports

Positive Surprise Ratio

ONC beat 5 of 17 last estimates.

29%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

BeOne Medicines Ltd. - ADR earnings per share and revenue

On May 06, 2026, ONC reported earnings of 13.35 USD per share (EPS) for Q1 26, beating the estimate of 1.32 USD, resulting in a 2597.62% surprise. Revenue reached 10.31 billion, compared to an expected 10.93 billion, with a -1.83% difference. The market reacted with a +5.32% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q1 2026, BeOne Medicines Ltd. - ADR reported EPS of $13.35, beating estimates by 2597.62%, and revenue of $10.31B, -1.83% below expectations.
The stock price moved up 5.32%, changed from $297.49 before the earnings release to $313.32 the day after.
The next earning report is scheduled for --.
Based on -- analysts, BeOne Medicines Ltd. - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement